Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Notarfranchi

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Current Opinion in Hematology|February 11, 2026
Advances in the pathophysiology and treatment of anaemia in multiple myelomaNicola Giuliani, Benedetta Dalla Palma, Laura Notarfranchi
Frontiers in Oncology|July 26, 2021
Mechanisms of Action of the New Antibodies in Use in Multiple MyelomaAlessandra Romano, Paola Storti, Valentina Marchica, et al.
Frontiers in Immunology|February 22, 2021
Phase II Trial of Maintenance Treatment With IL2 and Zoledronate in Multiple Myeloma After Bone Marrow Transplantation: Biological and Clinical ResultsRita Fazzi, Iacopo Petrini, Nicola Giuliani, et al.
Acta Haematologica|September 9, 2020
Concomitant Primary Hyperparathyroidism in Patients with Multiple Myeloma: A Possible Link?Laura Notarfranchi, Valentina Marchica, Benedetta Dalla Palma, et al.
Frontiers in Immunology|January 25, 2021
PD-L1/PD-1 Pattern of Expression Within the Bone Marrow Immune Microenvironment in Smoldering Myeloma and Active Multiple Myeloma PatientsFederica Costa, Rosanna Vescovini, Valentina Marchica, et al.
Oncotarget|December 13, 2019
Mesangiogenic progenitor cells are forced toward the angiogenic fate, in multiple myelomaSimone Pacini, Marina Montali, Francesco Mazziotta, et al.
Cancers|May 28, 2020
Application of Next-Generation Sequencing for the Genomic Characterization of Patients with Smoldering MyelomaMartina Manzoni, Valentina Marchica, Paola Storti, et al.
Case Reports in Hematology|April 14, 2018
A Rare Case of Systemic AL Amyloidosis with Muscle Involvement: A Misleading DiagnosisFabrizio Accardi, Valentina Papa, Anna Rita Capozzi, et al.
Frontiers in Immunology|March 5, 2025
Follow-up of humoral and cellular immune responses after the third SARS-CoV-2 vaccine dose in multiple myeloma patientsVincenzo Raimondi, Paola Storti, Rosanna Vescovini, et al.
Hematology Reports|May 4, 2018
Neurofibromatosis type I and multiple myeloma coexistence: A possible link?Fabrizio Accardi, Valentina Marchica, Cristina Mancini, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Current Opinion in Hematology|February 11, 2026
Advances in the pathophysiology and treatment of anaemia in multiple myelomaNicola Giuliani, Benedetta Dalla Palma, Laura Notarfranchi
Frontiers in Oncology|July 26, 2021
Mechanisms of Action of the New Antibodies in Use in Multiple MyelomaAlessandra Romano, Paola Storti, Valentina Marchica, et al.
Frontiers in Immunology|February 22, 2021
Phase II Trial of Maintenance Treatment With IL2 and Zoledronate in Multiple Myeloma After Bone Marrow Transplantation: Biological and Clinical ResultsRita Fazzi, Iacopo Petrini, Nicola Giuliani, et al.
Acta Haematologica|September 9, 2020
Concomitant Primary Hyperparathyroidism in Patients with Multiple Myeloma: A Possible Link?Laura Notarfranchi, Valentina Marchica, Benedetta Dalla Palma, et al.
Frontiers in Immunology|January 25, 2021
PD-L1/PD-1 Pattern of Expression Within the Bone Marrow Immune Microenvironment in Smoldering Myeloma and Active Multiple Myeloma PatientsFederica Costa, Rosanna Vescovini, Valentina Marchica, et al.
Oncotarget|December 13, 2019
Mesangiogenic progenitor cells are forced toward the angiogenic fate, in multiple myelomaSimone Pacini, Marina Montali, Francesco Mazziotta, et al.
Cancers|May 28, 2020
Application of Next-Generation Sequencing for the Genomic Characterization of Patients with Smoldering MyelomaMartina Manzoni, Valentina Marchica, Paola Storti, et al.
Case Reports in Hematology|April 14, 2018
A Rare Case of Systemic AL Amyloidosis with Muscle Involvement: A Misleading DiagnosisFabrizio Accardi, Valentina Papa, Anna Rita Capozzi, et al.
Frontiers in Immunology|March 5, 2025
Follow-up of humoral and cellular immune responses after the third SARS-CoV-2 vaccine dose in multiple myeloma patientsVincenzo Raimondi, Paola Storti, Rosanna Vescovini, et al.
Hematology Reports|May 4, 2018
Neurofibromatosis type I and multiple myeloma coexistence: A possible link?Fabrizio Accardi, Valentina Marchica, Cristina Mancini, et al.
Pageof 2